Postmenopausal Hormone Therapy in Unstable Angina
NCT00000601 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL
Last updated 2016-02-18
Summary
To determine if estrogen therapy in postmenopausal women with unstable angina reduces the incidence of ischemic episodes.
Conditions
- Angina, Unstable
- Cardiovascular Diseases
- Coronary Disease
- Heart Diseases
- Postmenopause
Interventions
- DRUG
-
estrogen replacement therapy
- DRUG
-
estrogens
- DRUG
-
progesterone
- DRUG
-
hormone replacement therapy
Sponsors & Collaborators
-
National Heart, Lung, and Blood Institute (NHLBI)
lead NIH
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- DOUBLE
Eligibility
- Min Age
- 45 Years
- Max Age
- 75 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-07-31
- Completion
- 2000-06-30
More Related Trials
-
Postmenopausal Progestins, MI and Stroke
NCT00005220 ·Status: COMPLETED
-
Hormone Replacement Therapy and Prothrombotic Variants
NCT00049933 ·Status: COMPLETED
-
Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
NCT00005108 ·Status: COMPLETED ·Phase: PHASE2
-
Endogenous Estrogen and Coronary Heart Disease in Women
NCT00005446 ·Status: COMPLETED
-
Estrogen, HDL, and Coronary Heart Disease in Women
NCT00083824 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Vascular and Metabolic Effects of Hormone Therapy Combined With L-Arginine in Postmenopausal Women
NCT00001752 ·Status: COMPLETED ·Phase: PHASE2
-
Hormonal Replacement Therapy and Small Artery Function
NCT00564031 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Roles of Estrogen and Progesterone in Heart Metabolism
NCT00565916 ·Status: TERMINATED ·Phase: NA
-
CVD Risk and Health in Postmenopausal Phytoestrogen Users
NCT00000613 ·Status: COMPLETED ·Phase: PHASE2
-
Estrogen and Graft Atherosclerosis Research Trial (EAGER)
NCT00000605 ·Status: COMPLETED ·Phase: PHASE3
-
Hormone Replacement and Neural Cardiovascular Control in Postmenopausal Women
NCT01633814 ·Status: TERMINATED ·Phase: NA
-
Postmenopausal Estrogen/Progestin Interventions (PEPI)
NCT00000466 ·Status: COMPLETED ·Phase: PHASE3
-
Bioidentical 'Natural' Hormone Evaluation in Early Menopause
NCT00302731 ·Status: TERMINATED ·Phase: PHASE2
-
Effects of Hormone Replacement Therapy on Cardiovascular Risk and Body Composition Parameters
NCT04453332 ·Status: UNKNOWN ·Phase: NA
-
Hormone Replacement Therapy in Relieving Menopausal Symptoms in Postmenopausal Women With Previous Stage I or Stage II Breast Cancer
NCT00079248 ·Status: UNKNOWN ·Phase: NA
-
Effects of Estradiol on Menopausal Breast
NCT00785317 ·Status: UNKNOWN ·Phase: PHASE4
-
Hormone Estradiol Replacement Therapy Additional Herbals
NCT02618148 ·Status: COMPLETED ·Phase: PHASE4
-
Women's Estrogen/Progestin Lipid Lowering Hormone Atherosclerosis Regression Trial (WELL-HART)
NCT00000559 ·Status: COMPLETED ·Phase: PHASE3
-
Reducing the Risk of Drug-Induced QT Interval Lengthening in Women
NCT03834883 ·Status: COMPLETED ·Phase: PHASE4
-
Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
NCT04050592 ·Status: UNKNOWN ·Phase: PHASE4
-
Reduction of Triglycerides in Women on Hormone Replacement Therapy
NCT00023543 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Vascular Findings Between Symptomatic and Asymptomatic Postmenopausal Women Before and During Hormone Therapy (HRT)
NCT00668603 ·Status: COMPLETED ·Phase: NA
-
Menopause Effects on Vascular Function
NCT03236545 ·Status: COMPLETED ·Phase: NA
-
Midlife Cholesterol Study
NCT00361075 ·Status: COMPLETED ·Phase: PHASE4
-
Sex Steroid Hormones and Risk of CHD in Women
NCT00006407 ·Status: COMPLETED